Cytek Biosciences, Inc.
CTKB· Nasdaq
Released Mar 1, 2024, before the open
10-K filed Mar 13, 2024, 73 days after period end · 0001628280-24-010933
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | $58.23M | $48.34M | $38.89M | — |
| Net Income | $5.50M |
Cytek Biosciences, Inc. · CIK 1831915 · Engraved from SEC EDGAR
| $3.72M |
| -$1.17M |
| $5.60M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.